Pichia Fermentation Process Guidelines
人工流产综合症抢救流程

人工流产综合症抢救流程英文回答:Abortion complications can be serious and require immediate medical attention. The management ofcomplications from induced abortion depends on the specific situation and the severity of the symptoms. Here is a general outline of the steps involved in the rescue process for complications related to induced abortion:1. Assessment and stabilization: The first step is to assess the patient's condition and stabilize them if necessary. This may involve checking vital signs, administering intravenous fluids, and providing pain relief.2. Diagnosis: The healthcare provider will conduct a thorough evaluation to determine the nature and extent ofthe complications. This may include a physical examination, ultrasound, blood tests, and other diagnostic procedures.3. Treatment of complications: The specific treatment will depend on the complications present. Some possible interventions include:Infection management: Antibiotics may be prescribed to treat or prevent infection.Hemorrhage control: If there is excessive bleeding, medications or procedures such as dilation and curettage (D&C) may be performed to stop the bleeding.Retained products of conception: If there are remaining fetal tissues in the uterus, a D&C or medication may be used to remove them.Pain management: Pain medications may be given to alleviate discomfort.Emotional support: Counseling or support services may be provided to help the patient cope with the emotional aspects of the situation.4. Follow-up care: After the initial treatment, the patient will require follow-up care to ensure proper healing and monitor for any further complications. This may involve additional visits to the healthcare provider, medication administration, or further diagnostic tests.It is important to note that the above steps are a general guideline, and the actual management of complications may vary depending on the individual case. It is crucial to seek immediate medical attention if you experience any complications following an induced abortion.中文回答:人工流产的并发症可能很严重,需要立即就医。
海洋黏细菌防治甘蔗梢腐病的筛选评价

南方农业学报 Journal of Southern Agriculture 2023,54(11):3265-3276ISSN 2095-1191; CODEN NNXAABDOI:10.3969/j.issn.2095-1191.2023.11.014海洋黏细菌防治甘蔗梢腐病的筛选评价官佳松1,2,卢天梅2,邹承武1,蒙姣荣1,马仲辉1,苏志维2*(1广西大学农学院/广西甘蔗生物学重点实验室,广西南宁530004;2广西中医药大学海洋药物研究院/广西海洋药物重点实验室,广西南宁530200)摘要:【目的】明确来源于广西北部湾的海洋黏细菌对甘蔗梢腐病病原真菌的生物防治潜力,为研发有效防治甘蔗梢腐病的生物农药提供科学依据和物质基础。
【方法】以来源于广西北部湾不同海洋生境的12种62株黏细菌为研究对象,以2株广西蔗区甘蔗梢腐病优势病原菌甘蔗镰孢菌(Fusarium sacchari)9DF-3-2和FS-2-1为靶标,通过平板对峙培养法评价黏细菌对甘蔗镰孢菌的拮抗作用,初步筛选出潜力活性菌株;利用透析膜对峙培养法、菌丝裂解法和菌丝生长速率法等从拮抗作用方式、对病原菌菌丝生长的影响等方面评价潜力活性菌株对甘蔗镰孢菌的生物防治潜力。
【结果】通过平板对峙培养法从62株黏细菌中发现47株黏细菌对2株甘蔗镰孢菌9DF-3-2和FS-2-1具有明显的抑制作用,其活性菌株率达75.8%,有18株黏细菌对2株甘蔗镰孢菌的抑菌直径大于1.000 cm,其中以叶柄黏球菌(Myxococ‐cus stipitatus)T163和蜂窝囊菌(Melittangium sp.)T269的抑制作用最强。
黏细菌胞外发酵液对甘蔗镰孢菌菌丝裂解试验结果显示,黏细菌T163和T269的胞外发酵液对2株甘蔗镰孢菌的菌丝抑制作用最明显;透析膜平板隔离试验结果显示,黏细菌T269、T163和T071受透析膜隔离后对甘蔗镰孢菌仍具有很好的抑制作用;黏细菌发酵提取物抗菌活性测定结果显示,黏细菌T163和T269的发酵提取物对2株甘蔗镰孢菌均具有较好的抑制作用,其中浓度为100.0 μg/mL)分别为13.97和84.58 μg/mL。
申请慢病理流程手续

申请慢病理流程手续The process of applying for chronic disease treatment procedures can be overwhelming and confusing. 申请慢病治疗程序的过程可能令人感到不知所措和困惑。
It involves a series of steps and requirements that need to be followed carefully in order to ensure a successful application. 这涉及一系列必须仔细遵循的步骤和要求,以确保成功申请。
From gathering the necessary documents to filling out the application forms, there are various aspects to consider when applying for chronic disease treatment procedures. 从收集必要文件到填写申请表格,申请慢病治疗程序时需要考虑各个方面。
One of the first steps in the process is to consult with a healthcare provider to discuss the treatment options available. 过程中的第一步之一是咨询医疗服务提供者,讨论可用的治疗选项。
They can provide valuable information and guidance on the process of applying for chronic disease treatment procedures. 他们可以提供有关申请慢病治疗程序的过程的宝贵信息和指导。
In addition to consulting with a healthcare provider, it is important to gather all necessary documents for the application process. 除了咨询医疗服务提供者外,收集所有必要文件对于申请程序至关重要。
非酿酒酵母与酿酒酵母混合发酵柿子酒特性的研究

非酿酒酵母与酿酒酵母混合发酵柿子酒特性的研究荆雄;杨辉;苏文;董腾达;黄莎莎【摘要】基于非酿酒酵母代谢产物可提升酒的香气和风味物质,将两种非酿酒酵母柠檬形克勒克酵母(Klockera apiculata)和东方伊萨酵母(Issatchenkia orientalis)用于柿子酒发酵,研究两种非酿酒酵母对酒精、二氧化硫、单宁的耐受性和产β-葡萄糖苷酶的能力;对它们分别与酿酒酵母(Saccharomyces cerevisiae)混合发酵柿子酒的特性进行研究.结果表明,东方伊萨酵母在各方面耐受性均优于柠檬形克勒克酵母,但产β-葡萄糖苷酶的能力却较弱;两种非酿酒酵母单菌发酵性能都较弱,东方伊萨酵母单菌发酵结束酒精度为4.51%vol,而柠檬形克勒克酵母单菌发酵酒精度只有3.05%vol;两种非酿酒酵母与酿酒酵母混菌发酵7d后,酒精度均达到10%vol以上.【期刊名称】《中国酿造》【年(卷),期】2018(037)012【总页数】5页(P52-56)【关键词】柠檬形克勒克酵母;东方伊萨酵母;酿酒酵母;发酵;柿子酒;特性【作者】荆雄;杨辉;苏文;董腾达;黄莎莎【作者单位】陕西科技大学食品与生物工程学院,陕西西安710021;陕西科技大学食品与生物工程学院,陕西西安710021;陕西科技大学食品与生物工程学院,陕西西安710021;陕西科技大学食品与生物工程学院,陕西西安710021;陕西科技大学食品与生物工程学院,陕西西安710021【正文语种】中文【中图分类】TS261.1我国柿子种植面积广、产量高,特别是近年来柿子产量大幅度提高,而柿子鲜食消费市场却相对有限,柿子成熟后一旦不及时采摘加工,很容易软化、腐烂,造成极大经济损失[1]。
由于柿子中具有丰富的生物活性物质(如甘露醇、果糖、五环三萜类化合物、维生素和大量的鞣质等),因此可以做成高档调味品、柿子酒和各种保健品等[2-4]。
我国柿子酒的生产工业中多采用商用酵母单菌发酵,这类酵母具备耐高温、耐高酒精的特征,可确保果酒品质[5]。
重组毕赤酵母生产胰蛋白酶的中试发酵条件研究

重组毕赤酵母生产胰蛋白酶的中试发酵条件研究摘要:本研究用7.5L发酵罐对胰蛋白酶毕赤酵母基因工程菌TRYP1的发酵培养基进行优化,结果表明最佳的发酵培养基为:40g/L甘油、30g/L酵母浸粉、60g/L 酵母蛋白胨、16g/L硫酸铵、10g/L七水合硫酸镁、10g/L氯化钾、0.3g/L二水合氯化钙、4mL/L微量元素PTM1。
并使用该发酵培养基进行了发酵工艺研究,结果表明最佳的发酵工艺为:培养阶段温度30℃,pH5.0,DO维持在20%~60%之间;诱导发酵液浓度(OD600)为200;诱导阶段温度25℃,pH4.0,DO维持在5%~50%之间。
在此基础上进行了20L罐的发酵中试,重组胰蛋白酶的产量达到7851U/ml,实现了高密度发酵,为胰蛋白酶的大规模工业化生产奠定了基矗关键词:重组毕赤酵母生产胰蛋白酶的中试发酵条件研究胰蛋白酶(EC 3.4.4.4)是一种丝氨酸蛋白酶,能选择地水解蛋白质中赖氨酸或精氨酸羧基末端的肽键,广泛用于动物细胞培养、生物制药、化工、洗涤等领域。
重组胰蛋白酶不含动物病毒、致病因子等风险物质,无糜蛋白酶、羧肽酶A等杂酶,特别适用于生物药物的生产。
目前胰蛋白酶已在大肠杆菌中实现了表达重组【1-3】,但是胰蛋白酶原大多以包涵体形式存在,需要破碎细胞、提取包涵体、蛋白变性、复性、激活等步骤,工艺十分复杂,部分通过改变信号肽或增加融合伴侣的方式可以提高可溶性表达的比例,但后续纯化工艺仍然比较复杂,不利于大规模生产。
用毕赤酵母表达重组胰蛋白酶【4】时,胰蛋白酶原以可溶形式分泌到细胞外培养基中,无需破碎、变性、复性等步骤,纯化工艺简单。
但是在工业发酵过程中,胰蛋白酶原容易自我激活,成为活化胰蛋白酶,对宿主细胞产生毒害作用,从而导致目的蛋白降解,宿主细胞死亡,导致胰蛋白酶产量过低。
本研究用7.5L发酵罐对胰蛋白酶毕赤酵母基因工程菌TRYP1的发酵培养基进行优化,并对关键的发酵参数进行摸索,有效降低了胰蛋白酶对毕赤酵母细胞的毒害作用,延长了表达时间,实现了重组胰蛋白酶的高密度发酵,为大规模工业化生产奠定了基矗1 材料与方法1.1材料1.1 .1菌株胰蛋白酶毕赤酵母基因工程菌TRYP1(Mut+His+),由珠海冀百康生物科技有限公司构建与保存。
甘氨酸降低复合菌快速发酵虾酱中的组胺含量

甘氨酸降低复合菌快速发酵虾酱中的组胺含量于靖1,杨锡洪1,2,谢静雯1,卢宽1,解万翠1,2,3,4(1.青岛科技大学海洋科学与生物工程学院,山东青岛 266042)(2.山东省生物化学工程重点实验室,山东青岛 266042)(3.青岛智科检验检测有限公司,山东青岛 266002)(4.青岛信和源生物科技有限公司,山东青岛 266002)摘要:降低组胺及提高风味是快速发酵虾酱产业化面临的瓶颈问题。
为探讨甘氨酸对快速发酵虾酱中组胺生成的抑制作用及风味品质影响,本研究以新鲜虾头为原料,添加Pichia gilliermondii、Aspergillus niger及Lactobacillus planticola(1:3:5)的复合菌相发酵剂,检测添加甘氨酸后组胺含量变化,追踪对发酵过程中理化性质及安全指标影响,感官评定及电子鼻分析虾酱品质及风味。
结果表明,甘氨酸的添加对组胺生成有良好的抑制作用,向虾酱中添加2%、4%和6%的甘氨酸分别使组胺含量降低了29.53%、31.16%和34.98%,随甘氨酸添加量的增加,虾酱中AA-N含量增加,pH降低,菌落总数维持在3.77~4.15 lg(cfu/g)之间,产品安全性良好。
甘氨酸添加量为4%时,含硫化合物及芳香化合物传感器响应值增大,增强了虾酱的特征性风味,提高营养及感官风味水平。
定量添加的甘氨酸,既提高了产品的风味品质,又在一定程度上降低了组胺含量,保障产品安全性。
关键词:甘氨酸;快速发酵;组胺;虾酱;电子鼻文章篇号:1673-9078(2021)03-115-123 DOI: 10.13982/j.mfst.1673-9078.2021.3.0707 Glycine Reduces the Histamine Content in the Fast-fermented ShrimpPaste by Compound BacteriaYU Jing1, YANG Xi-hong1,2, XIE Jing-wen1, LU Kuan1, XIE Wan-cui1,2,3,4(1.College of Marine Science and Biological Engineering, Qingdao University of Science & Technology, Qingdao 266042,China)(2.Key Laboratory of Biochemical Engineering of Shandong Province, Qingdao 266042, China)(3.Qingdao Zhike Inspection and Testing Co. Ltd., Qingdao 266002, China)(4.Qingdao Xinheyuan Biotechnology Co. Ltd., Qingdao 266002, China)Abstract: Reducing histamine and improving flavor are the bottleneck problems in the industrialization of fast-fermented shrimp paste. In order to explore the inhibitory effect of glycine on the production of histamine in the fast-fermented shrimp paste and the effect on the flavor quality of the shrimp paste, this study used fresh shrimp heads as raw materials, with Pichia gilliermondii, Aspergillus niger and Lactobacillus planticola (1:3:5) as a compound fermentation agent. The changes in histamine content after the addition of glycine were examined, with the effects on the physicochemical properties and safety indicators during fermentation being tracked. The quality and flavor of shrimp paste were analyzed by sensory evaluation and electronic nose. The results showed that the addition of glycine had a significant inhibitory effect on histamine production. The addition of 2%, 4% or 6% of glycine to the shrimp paste reduced the histamine content by 29.53%, 31.16% and 34.98%, respectively. With an increase in the amount of glycine added, the content of AA-N in the shrimp paste increased. As the pH decreased, the total number of colonies was maintained in the range of 3.77~4.15 lg (cfu/g), while the product safety remained good. When the addition amount of glycine was 4%, the sensor response values of sulfur compounds and aromatic compounds increased, which enhanced the characteristic flavor of shrimp paste and improved the nutritional value and sensory flavor. The quantitative addition of glycine not only 引文格式:于靖,杨锡洪,谢静雯,等.甘氨酸降低复合菌快速发酵虾酱中的组胺含量[J].现代食品科技,2021,37(3):115-123YU Jing, Y ANG Xi-hong, XIE Jing-wen, et al. Glycine reduces the histamine content in the fast-fermented shrimp paste by compound bacteria [J]. Modern Food Science and Technology, 2021, 37(3): 115-123收稿日期:2020-07-26基金项目:国家自然科学基金项目(31671825;32072348);山东省重点研发计划项目(2017GHY15127)作者简介:于靖(1997-),女,在读硕士,研究方向:食品营养与安全通讯作者:解万翠(1969-),女,博士,教授,研究方向:食品风味与安全115improves the flavor quality of the product, but also reduces the histamine content to a certain extent to ensure product safety.Key words:glycine; rapid fermentation; histamine; shrimp paste; electronic nose虾酱(shrimp paste)是中国沿海地区以及马来西亚、新加坡、泰国等东南亚国家常见的海鲜调味品[1],以毛虾、蜢子虾等小型虾类及虾产品加工下脚料为原料,经虾体和细菌中蛋白酶对原料蛋白的水解,释放出氨基酸和肽,从而赋于产品特定的鲜美风味[2]。
指南中推荐意见的形成英文

指南中推荐意见的形成英文The Formulation of Recommendations in GuidelinesThe development of clinical practice guidelines is a critical process in the field of healthcare, as these guidelines serve as a valuable tool to guide healthcare professionals in delivering evidence-based and high-quality care. One of the key components of this process is the formulation of recommendations, which are the core of any guideline. The recommendations provide healthcare professionals with clear and concise guidance on the most appropriate course of action for specific clinical scenarios.The formulation of recommendations in guidelines is a complex and multifaceted process that involves a careful consideration of various factors. These factors include the quality and strength of the available evidence, the potential benefits and harms of the proposed interventions, the preferences and values of patients, and the feasibility and cost-effectiveness of the recommendations.One of the primary considerations in the formulation of recommendations is the quality and strength of the available evidence. Guideline developers must carefully evaluate the existingresearch on the topic at hand, assessing the methodological rigor, study design, and overall quality of the evidence. This assessment is crucial in determining the confidence that can be placed in the recommendations.In cases where the available evidence is strong and of high quality, the recommendations can be made with a greater degree of confidence. However, in situations where the evidence is limited or of lower quality, guideline developers must exercise caution and consider the potential uncertainties and limitations of the available data. In such instances, the recommendations may be qualified or presented with a lower level of certainty.Another important factor in the formulation of recommendations is the consideration of the potential benefits and harms of the proposed interventions. Guideline developers must weigh the potential positive outcomes, such as improved patient outcomes, reduced morbidity, or decreased healthcare costs, against the potential negative consequences, such as adverse effects, increased resource utilization, or patient burden.This careful balancing act is essential in ensuring that the recommendations strike the right balance between promoting optimal patient care and minimizing potential harm. Guideline developers may also consider the preferences and values of patients,as these can play a significant role in the acceptability and uptake of the recommendations.The feasibility and cost-effectiveness of the recommendations are also crucial considerations in the formulation process. Guideline developers must assess whether the proposed interventions are practical to implement within the healthcare system, taking into account factors such as resource availability, infrastructure, and provider expertise. Additionally, the cost-effectiveness of the recommendations must be evaluated to ensure that they represent a wise use of healthcare resources.The process of formulating recommendations in guidelines is further complicated by the need to account for contextual factors, such as local healthcare systems, cultural norms, and resource constraints. Guideline developers must carefully consider how these factors may impact the applicability and implementation of the recommendations in different settings.To address this challenge, many guideline development organizations have adopted the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. The GRADE system provides a structured framework for evaluating the quality of evidence and the strength of recommendations, taking into account factors such as the risk of bias, the consistency ofresults, the directness of the evidence, and the precision of the estimates.By using the GRADE approach, guideline developers can provide healthcare professionals with clear and transparent information about the level of confidence they can have in the recommendations, as well as the rationale behind the formulation of those recommendations.In conclusion, the formulation of recommendations in clinical practice guidelines is a complex and multifaceted process that requires careful consideration of a range of factors. Guideline developers must balance the quality and strength of the available evidence, the potential benefits and harms of the proposed interventions, the preferences and values of patients, and the feasibility and cost-effectiveness of the recommendations. By adopting a structured and transparent approach, such as the GRADE system, guideline developers can ensure that the recommendations they provide are evidence-based, patient-centered, and ultimately effective in improving the quality of healthcare delivery.。
重组牛乳铁蛋白功能片段在毕赤酵母中的表达及高密度发酵

1.2方法
1.2.1 重组酵母菌GS115fPIC9KFPTF'的构建与 筛选
提取 pPIC9K-BlfFf 重组质粒 DNA,用 Bpu1102
I线性化处理,电
赤酵母GS115 ,入1 mL预
冷的1 mol/L三梨醇,30 Q孵育2 h ,涂布于MD平板
中,30 Q静置培养72 h,
上 入 无 :并
His Tay ELISA DetyctOn KT试剂盒,南京金斯瑞%
1.1.4 培养基
LB、YPD、MD、BMGY 与 BMMY 配方参照 InviOe-
gen公司的《毕赤酵母
作手册》%
BSM 培养基 照 Pichia Feomeniaioon Guodeaones
2019年第45卷第1期(总第383期)29
DOI:10. 13995/j. akO 11 - 1802/ts. 019993
研究报告
重组牛乳铁蛋白功能片段在毕赤酵母中的表达及高密度发酵
魏春,任郑,吴涛,钱晓芬,孙杰,汪钊!
(浙江工业大学生物工程学院,浙江杭州,310014)
摘 要 该研究合成了密码子优化后的牛乳铁蛋白功能片段(bovine lactoferrin functional frayment,BlfFf),转入 毕赤酵母GS115中重组表达并筛选抗性菌株,通过银亲和层析纯化Blfff,以Western Blot、液质联用和ELISA对 重组蛋白进行鉴定及检测。比较了 5 L发酵罐生产中3种不同高密度发酵培养基对Biff生产的影响#结果表
30位和265 ~ 284位2个氨基酸结构域[12-14],而且
这2个小肽在空间结构上很相近,2个结构域裤
作起作用,这比单一结构域具有更强的
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Version B Pichia Fermentation Process GuidelinesOverviewIntroduction Pichia pastoris, like Saccharomyces cerevisiae, is particularly well-suited forfermentative growth. Pichia has the ability to reach very high cell densities duringfermentation which may improve overall protein yields.We recommend that only those with fermentation experience or those who have accessto people with experience attempt fermentation. Since there are a wide variety offermenters available, it is difficult to provide exact procedures for your particular case.The guidelines given below are based on fermentations of both Mut+ and Mut S Pichiastrains in a 15 liter table-top glass fermenter. Please read the operator's manual for yourparticular fermenter before beginning. The table below provides an overview of thematerial covered in these guidelines.Step Topic Page1 Fermentationparameters 12 Equipment needed and preparation of medium 23 Measurement and use of dissolved oxygen (DO) in the culture 34 Growth of the inoculum 45 Generation of biomass on glycerol in batch and fed-batch phases 4-56 Induction of expression of Mut+ and Mut S recombinants in themethanol fed-batch phase6-77 Harvesting and lysis of cells 88 References 9-109 Recipes 11Fermentation Parameters It is important to monitor and control the following parameters throughout thefermentation process. The following table describes the parameters and the reasons for monitoring them.Parameter Reason Temperature (30.0°C) Growth above 32°C is detrimental to protein expression Dissolved oxygen (>20%) Pichia needs oxygen to metabolize glycerol andmethanolpH (5.0-6.0 and 3.0) Important when secreting protein into the medium andfor optimal growthAgitation (500 to 1500 rpm) Maximizes oxygen concentration in the mediumAeration (0.1 to 1.0 vvm*for glass fermenters)Maximizes oxygen concentration in the medium whichdepends on the vesselAntifoam (the minimumneeded to eliminate foam)Excess foam may cause denaturation of your secretedprotein and it also reduces headspaceCarbon source (variablerate)Must be able to add different carbon sources at differentrates during the course of fermentationcontinued on next pageOverview, continuedRecommended Equipment Below is a checklist for equipment recommendations.• A jacketed vessel is needed for cooling the yeast during fermentation, especially during methanol induction. You will need a constant source of cold water (5-10°C). This requirement may mean that you need a refrigeration unit to keep the water cold. • A foam probe is highly recommended as antifoam is required.• A source of O2--either air (stainless steel fermenters at 1-2 vvm) or pure O2(0.1-0.3 vvm for glass fermenters).• Calibrated peristaltic pumps to feed the glycerol and methanol.• Automatic control of pH.Medium Preparation You will need to prepare the appropriate amount of following solutions:• Fermentation Basal Salts (page 11)• PTM1Trace Salts (page 11)• ~75 ml per liter initial fermentation volume of 50% glycerol containing 12 ml PTM1 Trace Salts per liter of glycerol.• ~740 ml per liter initial fermentation volume of 100% methanol containing 12 mlPTM1Trace Salts per liter of methanol.Monitoring the Growth of Pichia pastoris Cell growth is monitored at various time points by using the absorbance at 600 nm (OD600) and the wet cell weight. The metabolic rate of the culture is monitored by observing changes in the concentration of dissolved oxygen in response to carbon availability (see next page).Dissolved Oxygen (DO) MeasurementIntroduction The dissolved oxygen concentration is the relative percent of oxygen in the mediumwhere 100% is O2-saturated medium. Pichia will consume oxygen as it grows, reducing the dissolved oxygen content. However, because oxygen is required for the first step ofmethanol catabolism, it is important to maintain the dissolved oxygen (DO) concentra-tion at a certain level (>20%) to ensure growth of Pichia on methanol. Accuratemeasurement and observation of the dissolved oxygen concentration of a culture willgive you important information about the state and health of the culture. Therefore, it isimportant to accurately calibrate your equipment. Please refer to your operator's manual.Maintaining the Dissolved Oxygen Concentration (DO) 1. Maintaining the dissolved oxygen above 20% may be difficult depending on theoxygen transfer rates (OTR) of the fermenter, especially in small-scale glassvessels. In a glass vessel, oxygen is needed to keep the DO above 20%, usually~0.1-0.3 vvm (liters of O2per liter of fermentation culture per minute). Oxygen consumption varies and depends on the amount of methanol added and the protein being expressed.2. Oxygen can be used at 0.1 to 0.3 vvm to achieve adequate levels. This can beaccomplished by mixing with the air feed and can be done in any glass fermenter.For stainless steel vessels, pressure can be used to increase the OTR. Be sure toread the operator's manual for your particular fermenter.3. If a fermenter cannot supply the necessary levels of oxygen, then the methanol feedshould be scaled back accordingly. Note that decreasing the amount of methanol may reduce the level of protein expression.4. To reach maximum expression levels, the fermentation time can be increased todeliver similar levels of methanol at the lower feed rate. For many recombinantproteins, a direct correlation between amount of methanol consumed and theamount of protein produced has been observed.Use of DO Measurements During growth, the culture consumes oxygen, keeping the DO concentration low. Note that oxygen is consumed whether the culture is grown on glycerol or methanol. The DO concentration can be manipulated to evaluate the metabolic rate of the culture and whether the carbon source is limiting. The metabolic rate indicates how healthy the culture is. Determining whether the carbon source is limiting is important if you wish to fully induce the AOX1 promoter. For example, changes in the DO concentrations (DO spikes) allow you to determine whether all the glycerol is consumed from the culture before adding methanol. Secondly, it ensures that your methanol feed does not exceed the rate of consumption. Excess methanol (> 1-2% v/v) may be toxic.Manipulation of DO If carbon is limiting, shutting off the carbon source should cause the culture to decrease its metabolic rate, and the DO to rise (spike). Terminate the carbon feed and time how long it takes for the DO to rise 10%, after which the carbon feed is turned back on. If the lag time is short (< 1 minute), the carbon source is limiting.Fermenter Preparation and Glycerol Batch PhaseInoculum Seed Flask Preparation Remember not to put too much medium in the baffled flasks. Volume should be 10-30% of the total flask volume.1. Baffled flasks containing a total of 5-10% of the initial fermentation volume ofMGY or BMGY are inoculated with a colony from a MD or MGY plate or from a frozen glycerol stock.2. Flasks are grown at 30°C, 250-300 rpm, 16-24 hours until OD600= 2-6. Toaccurately measure OD600> 1.0, dilute a sample of your culture 10-fold before reading.Glycerol Batch Phase 1. Sterilize the fermenter with the Fermentation Basal Salts medium containing 4%glycerol (see page 11).2. After sterilization and cooling, set temperature to 30°C, agitation and aeration tooperating conditions (usually maximum rpm and 0.1-1.0 vvm air), and adjust the pH of the Fermentation Basal Salts medium to 5.0 with 28% ammonium hydroxide(undiluted ammonium hydroxide). Add aseptically 4.35 ml PTM1trace salts/liter of Fermentation Basal Salts medium.3. Inoculate fermenter with approximately 5-10% initial fermentation volume from theculture generated in the inoculum shake flasks. Note that the DO will be close to 100% before the culture starts to grow. As the culture grows, it will consumeoxygen, causing the DO to decrease. Be sure to keep the DO above 20% by adding oxygen as needed.4. Grow the batch culture until the glycerol is completely consumed (18 to 24 hours).This is indicated by an increase in the DO to 100%. Note that the length of timeneeded to consume all the glycerol will vary with the density of the initial inoculum.5. Sampling is performed at the end of each fermentation stage and at least twice daily.We take 10 ml samples for each time point, then take 1 ml aliquots from this 10 mlsample. Samples are analyzed for cell growth (OD600and wet cell weight), pH, microscopic purity, and protein concentrations or activity. Freeze the cell pellets and supernatants at -80°C for later analysis. Proceed to Glycerol Fed-Batch Phase,page 5.Yield A cellular yield of 90 to 150 g/liter wet cells is expected for this stage. Recombinant protein will not yet be produced due to the absence of methanol.Introduction Once all the glycerol is consumed from the batch growth phase, a glycerol feed isinitiated to increase the cell biomass under limiting conditions. When you are ready toinduce with methanol, you can use DO spikes to make sure the glycerol is limited.Glycerol Fed-Batch Phase 1. Initiate a 50% w/v glycerol feed containing 12 ml PTM1trace salts per liter of glycerol feed. Set the feed rate to 18.15 ml/hr /liter initial fermentation volume.2. Glycerol feeding is carried out for about four hours or longer (see below). A cellularyield of 180 to 220 g/liter wet cells should be achieved at the end of this stage while no appreciable recombinant protein is produced.Note The level of expressed protein depends on the cell mass generated during the glycerolfed-batch phase. The length of this feed can be varied to optimize protein yield. A rangeof 50 to 300 g/liter wet cells is recommended for study. A maximum level of 4%glycerol is recommended in the batch phase due to toxicity problems with higher levelsof glycerol.Important If dissolved oxygen falls below 20%, the glycerol or methanol feed should bestopped and nothing should be done to increase oxygen rates until the dissolvedoxygen spikes. At this point, adjustments can be made to agitation, aeration, pressure oroxygen feeding.Proteases In the literature, it has been reported that if the pH of the fermentation medium islowered to 3.0, neutral proteases are inhibited. If you think neutral proteases aredecreasing your protein yield, change the pH control set point to 3.0 during the glycerolfed-batch phase (above) or at the beginning of the methanol induction (next page) andallow the metabolic activity of the culture to slowly lower the pH to 3.0 over 4 to 5 hours(Brierley, et al., 1994; Siegel, et al., 1990).Alternatively, if your protein is sensitive to low pH, it has been reported that inclusion ofcasamino acids also decreases protease activity (Clare, et al., 1991).Introduction All of the glycerol needs to be consumed before starting the methanol feed to fullyinduce the AOX1 promoter on methanol. However, it has been reported that a "mixedfeed" of glycerol and methanol has been successful to express recombinant proteins(Brierley, et al., 1990; Sreekrishna, et al., 1989). It is important to introduce methanolslowly to adapt the culture to growth on methanol. If methanol is added too fast, it willkill the cells. Once the culture is adapted to methanol, it is very important to use DOspikes to analyze the state of the culture and to take time points over the course ofmethanol induction to optimize protein expression. Growth on methanol also generates alot of heat, so temperature control at this stage is very important.Mut+ Methanol Fed-Batch Phase 1. Terminate glycerol feed and initiate induction by starting a 100% methanol feedcontaining 12 ml PTM1trace salts per liter of methanol. Set the feed rate to 3.6 ml/hr per liter initial fermentation volume.2. During the first 2-3 hours, methanol will accumulate in the fermenter and thedissolved oxygen values will be erratic while the culture adapts to methanol.Eventually the DO reading will stabilize and remain constant.3. If the DO cannot be maintained above 20%, stop the methanol feed, wait for theDO to spike and continue on with the current methanol feed rate. Increaseagitation, aeration, pressure or oxygen feeding to maintain the DO above 20%. 4. When the culture is fully adapted to methanol utilization (2-4 hours), and is limitedon methanol, it will have a steady DO reading and a fast DO spike time (generally under 1 minute). Maintain the lower methanol feed rate under limited conditions for at least 1 hour after adaptation before doubling the feed. The feed rate is then doubled to ~7.3 ml/hr/liter initial fermentation volume.5 After 2 hours at the 7.3 ml/hr/liter feed rate, increase the methanol feed rate to~10.9 ml/hr per liter initial fermentation volume. This feed rate is maintainedthroughout the remainder of the fermentation.6. The entire methanol fed-batch phase lasts approximately 70 hours with a total ofapproximately 740 ml methanol fed per liter of initial volume. However, this may vary for different proteins.Note: The supernatant may appear greenish. This is normal.Yield The cell density can increase during the methanol fed-batch phase to a final level of 350 to 450 g/liter wet cells. Remember that because most of the fermentation is carried out ina fed-batch mode, the final fermentation volume will be approximately double the initialfermentation volume.Fermentation of Mut S Pichia Strains Since Mut S cultures metabolize methanol poorly, their oxygen consumption is very low. Therefore, you cannot use DO spikes to evaluate the culture. In standard fermentations of a Mut S strain, the methanol feed rate is adjusted to maintain an excess of methanol in the medium which does not exceed 0.3% (may be determined by gas chromatography). While analysis by gas chromatography will insure that nontoxic levels of methanol are maintained, we have used the empirical guidelines below to express protein in Mut S strains. A gas chromatograph is useful for analyzing and optimizing growth of Mut S recombinants.continued on next pageMethanol Fed-Batch Phase, continuedMut S Methanol Fed- Batch Phase The first two phases of the glycerol batch and fed-batch fermentations of the Mut S strains are conducted as described for the Mut+ strain fermentations. The methanol induction phases of the Mut+ and Mut S differ in terms of the manner and amount in which the methanol feed is added to the cultures.1. The methanol feed containing 12 ml PTM1trace salts per liter of methanol is initiated at 1 ml/hr/liter initial fermentation volume for the first two hours. It is then increased in 10% increments every 30 minutes to a rate of 3 ml/hr which ismaintained for the duration of the fermentation.2.. The vessel is then harvested after ~100 hours on methanol. This time may be variedto optimize protein expression.Harvesting and Lysis of CellsIntroduction The methods and equipment listed below are by no means complete. The amount of cells or the volume of supernatant will determine what sort of equipment you need.Harvesting Cells and Supernatant For small fermentations (1-10 liters), the culture can be collected into centrifuge bottles (500-1000 ml) and centrifuged to separate the cells from the supernatant.For large fermentations, large membrane filtration units (Millipore) or a Sharples centrifuge can be used to separate cells from the supernatant. The optimal method will depend on whether you need the cells or the supernatant as the source of your protein and what you have available.Supernatants can be loaded directly onto certain purification columns or concentrated using ultrafiltration.Cell Lysis We recommend cell disruption using glass beads as described in Current Protocols inMolecular Biology, page 13.13.4. (Ausubel, et al., 1990) or Guide to ProteinPurification (Deutscher, 1990). This method may be tedious for large amounts of cells.For larger amounts, we have found that a microfluidizer works very well. Frenchpressing the cells does not seem to work as well as the glass beads or the microfluidizer.ReferencesIntroduction Most of the references below refer to papers where fermentation of Pichia wasperformed. Note that some of these are patent papers. You can obtain copies of patentsusing any of the following methods.• Patent Depository Libraries. U. S. patents and international patents granted underthe Patent Cooperation Treaty (PCT) are available on microfilm. These can be copiedand mailed or faxed depending on length. There is a fee for this service. The referencelibrarian at your local library can tell you the location of the nearest Patent DepositoryLibrary.• Interlibrary Loan. If you are not near a Patent Depository Library, you may request acopy of the patent through interlibrary loan. There will be a fee for this service.• U. S. Patent Office. Requests may be made directly to the Patent Office, Arlington,VA. Please call 703-557-4636 for more information on cost and delivery.• Private Library Services. There are private companies who will retrieve and sendyou patents for a fee. Two are listed below:Library Connection: 804-758-3311Rapid Patent Services: 800-336-5010Citations Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A.,Struhl, K., eds (1990) Current Protocols in Molecular Biology. GreenePublishing Associates and Wiley-Interscience, New York.Brierley, R. A., Siegel, R. S., Bussineau, C. M. Craig, W. S., Holtz, G. C., Davis, G. R.,Buckholz, R. G., Thill, G. P., Wondrack, L. M., Digan, M. E., Harpold, M. M.,Lair, S. V., Ellis, S. B., and William, M. E. (1989) Mixed Feed RecombinantYeast Fermentation. International Patent (PCT) Application. Publication No.WO 90/03431.Brierley, R. A., Bussineau, C., Kosson, R., Melton, A., and Siegel, R. S. (1990)Fermentation Development of Recombinant Pichia pastoris Expressing theHeterologous Gene: Bovine Lysozyme. Ann. New York Acad. Sci.589: 350-362.Brierley, R. A., Davis, G. R. and Holtz, G. C. (1994) Production of Insulin-Like GrowthFactor-1 in Methylotrophic Yeast Cells. United States Patent5,324,639.Clare, J. J., Romanos, M. A., Rayment, F. B., Rowedder, J. E., Smith, M. A., Payne, M.M., Sreekrishna, K. and Henwood, C. A. (1991) Production of EpidermalGrowth Factor in Yeast: High-level Secretion Using Pichia pastoris StrainsContaining Multiple Gene Copies. Gene105: 205-212.Cregg, J. M., Tschopp, J. F., Stillman, C., Siegel, R., Akong, M., Craig, W. S.,Buckholz, R. G., Madden, K. R., Kellaris, P. A., Davis, G. R., Smiley, B. L.,Cruze, J., Torregrossa, R., Veliçelebi, G. and Thill, G. P. (1987) High-levelExpression and Efficient Assembly of Hepatitis B Surface Antigen in theMethylotrophic Yeast Pichia pastoris. Bio/Technology5: 479-485.Cregg, J. M., Vedvick, T. S. and Raschke, W. C. (1993) Recent Advances in theExpression of Foreign Genes in Pichia pastoris. Bio/Technology11: 905-910.Deutscher, M. P. (1990) Guide to Protein Purification. In: Methods in Enzymology (J.N. Abelson and M. I. Simon, eds.) Academic Press, San Diego, CA.continued on next pageReferences, continuedCitations, continuedDigan, M. E., Lair, S. V., Brierley, R. A., Siegel, R. S., Williams, M. E., Ellis, S. B., Kellaris, P. A., Provow, S. A., Craig, W. S., Veliçelebi, G., Harpold, M. M. andThill, G. P. (1989) Continuous Production of a Novel Lysozyme via Secretionfrom the Yeast Pichia pastoris. Bio/Technology7: 160-164.Hagenson, M. J., Holden, K. A., Parker, K. A., Wood, P. J., Cruze, J. A., Fuke, M., Hopkins, T. R. and Stroman, D. W. (1989) Expression of Streptokinase inPichia pastoris Yeast. Enzyme Microbiol. Technol.11: 650-656.Laroche, Y., Storme, V., Meutter, J. D., Messens, J. and Lauwereys, M. (1994) High-Level Secretion and Very Efficient Isotopic Labeling of Tick AnticoagulantPeptide (TAP) Expressed in the Methylotrophic Yeast, Pichia pastoris.Bio/Technology12: 1119-1124.Romanos, M. A., Clare, J. J., Beesley, K. M., Rayment, F. B., Ballantine, S. P., Makoff,A. J., Dougan, G., Fairweather, N. F. and Charles, I. G. (1991) RecombinantBordetella pertussis Pertactin p69 from the Yeast Pichia pastoris High LevelProduction and Immunological Properties. Vaccine9: 901-906.Siegel, R. S. and Brierley, R. A. (1989) Methylotrophic Yeast Pichia pastoris Produced in High-cell-density Fermentations With High Cell Yields as Vehicle forRecombinant Protein Production. Biotechnol. Bioeng.34: 403-404.Siegel, R. S., Buckholz, R. G., Thill, G. P., and Wondrack, L. M. (1990) Production of Epidermal Growth Factor in Methylotrophic Yeast Cells. International Patent(PCT) Application. Publication No. WO 90/10697.Sreekrishna, K., Nelles, L., Potenz, R., Cruse, J., Mazzaferro, P., Fish, W., Fuke, M., Holden, K., Phelps, D., Wood, P. and Parker, K. (1989) High LevelExpression, Purification, and Characterization of Recombinant Human TumorNecrosis Factor Synthesized in the Methylotrophic Yeast Pichia pastoris.Biochemistry28(9): 4117-4125.©2002 Invitrogen Corporation. All rights reservedRecipesFermentation Basal Salts Medium For 1 liter, mix together the following ingredients:Phosphoric acid, 85% (26.7 ml)Calcium sulfate 0.93 gPotassium sulfate 18.2 gMagnesium sulfate-7H2O 14.9gPotassium hydroxide 4.13 gGlycerol 40.0g Water to 1 literAdd to fermenter with water to the appropriate volume and sterilize.PTM1 Trace Salts Mix together the following ingredients:Cupric sulfate-5H2O 6.0gSodium iodide 0.08 gManganese sulfate-H2O 3.0gSodium molybdate-2H2O 0.2gBoric Acid 0.02 g Cobalt chloride 0.5 g Zinc chloride 20.0 gFerrous sulfate-7H2O 65.0gBiotin 0.2gSulfuric Acid 5.0 mlWater to a final volume of 1 literFilter sterilize and store at room temperature.Note: There may be a cloudy precipitate upon mixing of these ingredients. Filter-sterilize as above and use.11。